Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol - Wikidata - wikimedia - TriplyDB

Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol

Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol

http://www.wikidata.org/entity/Q35536031

about

Role of biologics in severe eosinophilic asthma - focus on reslizumab Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran Defining severe asthma - an approach to find new therapies Unrecognised psychopathology in patients with difficult asthma: major mental and personality disorders.Omalizumab: the evidence for its place in the treatment of allergic asthma A systematic review of the implementation and impact of asthma protocols.Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry.Recommendation for optimal management of severe refractory asthma.PILL Series. The 'problematic' asthma patient A cross-sectional study evaluating the relationship between cortisol suppression and asthma control in patients with difficult asthma.Steroid response in refractory asthmatics Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry.The association between gastro-oesophageal reflux disease and asthma: a systematic review.Can severe asthmatic patients achieve asthma control? A systematic approach in patients with difficult to control asthma followed in a specialized clinic.Difficult asthma in adults: recognition and approaches to management.Clinical and molecular aspects of glucocorticoid resistant asthma An overview of chronic severe asthma.An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.Refractory asthma - An old disorder: Novel approaches for effective control The role of rhinosinusitis in severe asthma.Current treatment of severe asthma.Exacerbations of severe asthma.The investigation of severe asthma to define phenotypes.'SIMPLES': a structured primary care approach to adults with difficult asthma.Non-adherence in difficult asthma and advances in detection.Psychopathology in difficult asthma.Assessment of asthma severity and control.Diagnosis and investigation in the severe asthma clinic.Targeted therapeutics for severe refractory asthma: monoclonal antibodies.Co-morbidities in severe asthma: Clinical impact and management.Validated questionnaires heighten detection of difficult asthma comorbidities.Problematic severe asthma in children treated at high altitude: tapering the dose while improving control.The prevalence of nonadherence in difficult asthma.Frequent exacerbators--a distinct phenotype of severe asthma.The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma.A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial.Comorbid "treatable traits" in difficult asthma: Current evidence and clinical evaluation.Relationship between lung function and asthma symptoms in patients with difficult to control asthma.Multidimensional assessment of severe asthma: A systematic review and meta-analysis.Comorbidities in difficult asthma are independent risk factors for frequent exacerbations, poor control and diminished quality of life.

P2860

Q26738503-995C4E90-E737-4281-B20B-E1376BCA1C83 Q26777154-48474B87-562E-496C-AFAA-2E7E490299DB Q27001054-02947681-EC0F-4D14-A98E-B6C3526B18FA Q30489960-BBFC1A44-412D-4F18-9605-3A2A4B9073ED Q33973970-90242B4B-8FF7-4C0F-BFA6-DB453386CC5A Q34240522-1D41BEAC-67E5-4E94-AAB7-3CC356F4393D Q34289134-032C06E7-7FEF-46A3-A413-749355B907C9 Q34620187-A053AC8D-1138-4503-9705-88453D4A8734 Q35905019-A5CD94E4-311F-483D-9284-281F97EBD9D2 Q36024948-8F27B19D-B13F-4AB5-AFC8-05E1B4EC7766 Q36025200-C74A1631-B1D9-4E5B-83F4-8E00BC61AB06 Q36110425-701D387D-C6D0-43B6-ADD6-50B3EE71B7F0 Q36172860-F585292C-46F5-4C9E-B63B-5D236C8C1AA7 Q36194527-412DBEAA-FCAC-4E3E-A94B-A06CE192D472 Q36232288-94E5E61F-EA64-4920-BC7B-B1115BA4C050 Q36645790-6E4BA645-AA68-489A-9AEE-15246B928792 Q37008989-3626FD6B-C1AA-4956-89BC-5E66EBF47B46 Q37150465-68E8A369-469E-493C-992C-94D7A159FCEB Q37171325-5C02458F-63E5-4CBE-B14E-DA2E0DD7BC33 Q37356487-0DCA0073-F7E5-486B-B67B-E4BA68F7180D Q37976485-48537B07-C8F5-40C0-B375-BF511926C20B Q38003660-911CD970-0A89-481D-B8AD-262D8DD9362E Q38003661-68771749-7F1C-4337-8422-4BA6A4EC5309 Q38131332-EFBA4C8E-37CA-4486-87EB-5CFC71C1E2D7 Q38155878-59385058-293E-4986-9C06-F790A6AE6124 Q38300006-E200B938-AA71-4697-8B93-7B5B8CDB3067 Q38579904-8FC01A7E-800E-4050-A376-0F328D2201B2 Q38770013-833B2335-40DF-48DC-93C9-3B74AA09C2E2 Q38790815-04012F4A-A992-4362-A659-CB65FA58B602 Q39192970-E2FECF7F-A497-4A16-941B-B33E20521C7F Q39313246-5AA9D2BF-EE93-42BB-B62F-DACA6BE170BF Q42631579-A6CB6C59-9BAF-4866-89DF-E600B6714BE2 Q45024989-16988F61-6E83-4E13-BE5D-7D0C5FCF7DDB Q45031378-D9103915-5431-4FA7-B5F2-9F9C19BC805E Q45846048-4D42C12D-991F-4814-94B1-8E8406C4DF0A Q47568455-26CAF389-8025-47FA-A3A5-0463490217E2 Q47659621-795ED6EF-684B-4173-8173-13F546FFC689 Q47660055-DA2A330F-D4C0-4858-8E65-A58E5993AF0D Q47701122-577A2889-B52A-4FF6-9F5A-2240C96DEDC3 Q47710310-D608CB60-0AD8-48C0-A59D-C061CE6B0946

P2860

Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol

http://www.wikidata.org/entity/Q35536031

description

2003 nî lūn-bûn

@nan

2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol

@ast

Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol

@en

type

label

Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol

@ast

Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol

@en

prefLabel

Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol

@ast

Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol

@en

P1433

Q35536031-062FE1AE-9EA3-4B58-84F6-87C86851607C

P1476

Q35536031-E41ACF8E-5A25-4DBD-901F-328F584759A5

P2093

Q35536031-18DD4F04-F972-4738-9F2A-DB5D675BB659

Q35536031-2E2C0D8A-BE73-450A-87F1-047C1D618062

Q35536031-5ABC13A3-F512-4CAD-8B66-8AA7960EC406

Q35536031-70A07338-9BA8-470A-A3C6-0A6C65E84327

Q35536031-7C087875-615C-4CF5-B016-87267B510A6E

Q35536031-8352EF33-3A85-4B93-BBFB-DB006BBA8A7C

Q35536031-9AF64ABF-59BE-46FD-B603-217A120B8C72

P2860

Q35536031-0062AB31-D146-46FC-9D98-342403390F69

Q35536031-0A16E23B-A9AA-4EF9-95E8-B65F61256160

Q35536031-40BB41A7-C593-4701-B5F7-2AC916A0E8F5

Q35536031-46CC05E4-3CC5-42AB-9880-70D1192C919D

Q35536031-62EB4276-2E2A-40DD-9A52-9224EF9A6890

Q35536031-E4BB2A85-44A2-4A42-8F41-5FFC564A219C

Q35536031-F4485241-7492-4BA4-A4D2-B1CF8A6AB1A5

P304

Q35536031-CDAB1CB1-57E5-4D19-BDFC-31FD78725752

P31

Q35536031-E7447AC9-2DD2-449E-8579-54077C98C04B

P356

Q35536031-9D053B68-AB87-4275-8BA1-3B7D1023DE29

P407

Q35536031-AE25619C-2E59-4054-81B8-3240B49BD6A3

P433

Q35536031-35174020-E161-4F06-B46C-41ABA1A464E5

P478

Q35536031-EDBE3418-93A5-413E-BEEE-C584D2CFB4B7

P577

Q35536031-76BA0EB4-AD11-4CF9-9C61-56D49FD70E65

P5875

Q35536031-B2643AE6-809C-4206-81DD-65114D237E9F

P698

Q35536031-5AF6B44B-5A22-4B03-A103-90B3054A9699

P921

Q35536031-3DEEDF06-2057-4AE6-8E16-4BB0D0EA1EF3

P932

Q35536031-01CF0662-9054-4E99-BA4B-7C11EB967A56

P356

THORAX.58.7.561

P1433

P1476

Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol

@en

P2093

Conway E

http://www.w3.org/2001/XMLSchema#string

English C

http://www.w3.org/2001/XMLSchema#string

Gamble J

http://www.w3.org/2001/XMLSchema#string

Heaney LG

http://www.w3.org/2001/XMLSchema#string

Johnston BT

http://www.w3.org/2001/XMLSchema#string

Kelly C

http://www.w3.org/2001/XMLSchema#string

Stevenson M

http://www.w3.org/2001/XMLSchema#string

P2860

The hospital anxiety and depression scale

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respira

Efficacy and safety of inhaled corticosteroids. New developments.

Factors associated with persistent airflow limitation in severe asthma.

Association of forced expiratory volume with disease duration and sputum neutrophils in chronic asthma.

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

P304

561-566

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THORAX.58.7.561

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10685021

http://www.w3.org/2001/XMLSchema#string

P698

12832665

http://www.w3.org/2001/XMLSchema#string

P921

P932

1746731

http://www.w3.org/2001/XMLSchema#string